EGFR and nasopharyngeal carcinoma: Owing to its critical role, anti-EGFR therapy is considered to be an effective target in NPC treatment42, and therefore, it is necessary to clarify the specific mechanism of anti-EGFR targeted drugs in the treatment of nasopharyngeal carcinoma.